The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Open accessAbstract
OBJECTIVE: To report the autoantigens of a new category of treatment-responsive paraneoplastic encephalitis. METHODS: Analysis of clinical features, neuropathological findings, tumors, and serum/cerebrospinal fluid antibodies using rat tissue, neuronal cultures, and HEK293 cells expressing subunits of the N-methyl-D-aspartate receptor (NMDAR). RESULTS: Twelve women (14-44 years) developed prominent psychiatric symptoms, amnesia, seizures, frequent dyskinesias, autonomic dysfunction, and decreased level of consciousness often requiring ventilatory support. All had serum/cerebrospinal fluid antibodies that predominantly immunolabeled the neuropil of hippocampus/forebrain, in particular the cell surface of hippocampal neurons, and reacted with NR2B (and to a lesser extent NR2A) subunits of the NMDAR. NR2B binds glutamate and forms heteromers (NR1/NR2B or NR1/NR2A/NR2B) that are preferentially expressed in the adult hippocampus/forebrain. Expression of functional heteromers (not single subunits) was required for antibody binding. Eleven patients had teratoma of the ovary (six mature) and one a mature teratoma in the mediastinum; five of five tumors examined contained nervous tissue that strongly expressed NR2 subunits and reacted with patients' antibodies. Tumor resection and immunotherapy resulted in improvement or full recovery of eight of nine patients (paralleled by decreased antibody titers); two of three patients without tumor resection died of neurological deterioration. Autopsies showed extensive microgliosis, rare T-cell infiltrates, and neuronal degeneration predominantly involving, but not restricted to, the hippocampus. INTERPRETATION: Antibodies to NR2B- and NR2A-containing heteromers of the NMDAR associate with a severe but treatment-responsive encephalitis. Our findings provide a diagnostic test and suggest a model of autoimmune NMDAR-related encephalitis with broad implications for other immune-mediated disorders of memory, behavior, and cognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preliminary studies suggested the target epitopes were located in extracellular regions of NR1–NR2B NMDA receptors.5”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“We recently identified a disorder, designated anti-NMDA-receptor encephalitis, that associates with antibodies against NR1–NR2 heteromers and results in a characteristic neuropsychiatric syndrome.5”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“The first patients identified were young women with ovarian teratoma who presented with psychosis or memory problems, rapidly progressing to multiple neurological deficits requiring prolonged intensive care support.”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“Serum and CSF were tested for antibodies against the NMDA receptor,5 and considered positive if three immunohistochemical criteria were fulfilled (figure 1).”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“Despite the severity of the disorder, patients often recovered after tumour removal and immunotherapy, suggesting an immune-mediated pathogenesis.”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Gultekin, S. H. (2000) · Brain · doi:10.1093/brain/123.7.1481 · Cited by 1,110
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
Graus, F. (2001) · Brain · doi:10.1093/brain/124.6.1138 · Cited by 891
DeGiorgio, L. A., Konstantinov, K. N., Lee, S. C., Hardin, J., Volpe, B. T., & Diamond, B. (2001) · Nature Medicine · doi:10.1038/nm1101-1189 · Cited by 798
Clinical analysis of anti-Ma2-associated encephalitis
Dalmau, J. O. (2004) · Brain · doi:10.1093/brain/awh203 · Cited by 776
Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections
Cattoretti, G., Pileri, S. A., Parravicini, C., Becker, M. H. G., Poggi, S., Bifulco, C. B., Key, G., D'Amato, L., Sabattini, E., Feudale, E. A. A., et al. (1993) · The Journal of Pathology · doi:10.1002/path.1711710205 · Cited by 721
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma
Vitaliani, R., Mason, W. P., Ances, B. M., Zwerdling, T., Jiang, Z., & Dalmau, J. O. (2005) · Annals of Neurology · doi:10.1002/ana.20614 · Cited by 604
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Ances, B. M., Vitaliani, R., Taylor, R. A., Liebeskind, D. S., Voloschin, A. D., Houghton, D. J., Galetta, S. L., Dichter, M. A., Alavi, A. A., Rosenfeld, M. R., et al. (2005) · Brain · doi:10.1093/brain/awh526 · Cited by 486
Laube, B., Hirai, H., Sturgess, M., Betz, H., & Kuhse, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)81249-0 · Cited by 476
Wenzel, A., Fritschy, J., Möhler, H., & Benke, D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020469.x · Cited by 442
Flagged first, then by citations
Cited by
Sorted by citations
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
Self-citationTitulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi, I., Martinez-Hernandez, E., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70310-1 · Cited by 3,165
Self-citationClinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Dalmau, J. O., Lancaster, E., Martínez‐Hernández, E., Rosenfeld, M. R., & Balice‐Gordon, R. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70253-2 · Cited by 2,428
Lai, M., Huijbers, M. G. M., Lancaster, E., Graus, F., Bataller, L., Balice‐Gordon, R. J., Cowell, J. K., & Dalmau, J. O. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70137-x · Cited by 1,363
Gresa‐Arribas, N., Titulaer, M. J., Torrents, A., Aguilar, E., McCracken, L., Leypoldt, F., Gleichman, A. J., Balice‐Gordon, R. J., Rosenfeld, M. R., Lynch, D. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70282-5 · Cited by 1,306
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., Parsons, T. D., Lynch, D. R., Dalmau, J., & Balice-Gordon, R. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0167-10.2010 · Cited by 1,143
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents
Florance, N. R., Davis, R. L., Lam, C., Szperka, C., Zhou, L., Ahmad, S., Campen, C. J., Moss, H., Peter, N., Gleichman, A. J., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21756 · Cited by 1,090
Irani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
Dalmau, J. O., Armangué, T., Planagumà, J., Radosevic, M., Mannara, F., Leypoldt, F., Geis, C., Lancaster, E., Titulaer, M. J., Rosenfeld, M. R., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30244-3 · Cited by 918
Paraneoplastic syndromes of the CNS
Dalmau, J. O., & Rosenfeld, M. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70060-7 · Cited by 877
Predictive Processing: A Canonical Cortical Computation
Keller, G. B., & Mrsic-Flogel, T. D. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.003 · Cited by 836
Schwartz, J. E., Padmanabhan, A., Aqui, N. A., Balogun, R. A., Connelly‐Smith, L. S., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 799
Gable, M. S., Sheriff, H., Dalmau, J., Tilley, D. H., & Glaser, C. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir1038 · Cited by 733
Armangué, T., Spatola, M., Vlagea, A. D., Mattozzi, S., Carceles‐Cordon, M., Martínez‐Heras, E., Llufriú, S., Muchart, J., Erro, M. E., Abraira, L., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30244-8 · Cited by 665
Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin
Prüß, H., Dalmau, J. O., Harms, L., Höltje, M., Ahnert‐Hilger, G., Borowski, K., Stoecker, W., & Wandinger, K. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fc2a06 · Cited by 627
Dalmau, J. O., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 648
Petit‐Pedrol, M., Armangué, T., Peng, X., Bataller, L., Cellucci, T., Davis, R. A., McCracken, L., Martínez‐Hernández, E., Mason, W. P., Kruer, M. C., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70299-0 · Cited by 616
Schwartz, J. E., Winters, J. L., Padmanabhan, A., Balogun, R. A., Delaney, M., Linenberger, M. L., Szczepiorkowski, Z. M., Williams, M. E., Wu, Y., & Shaz, B. H. (2013) · Journal of Clinical Apheresis · doi:10.1002/jca.21276 · Cited by 610
Autoantibodies associated with diseases of the CNS: new developments and future challenges
Vincent, A. C., Bien, C. G., Irani, S. R., & Waters, P. J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70096-5 · Cited by 543
Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Titulaer, M. J., Soffietti, R., Dalmau, J. O., Ne, G., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Smitt, P. A. E. S., Tănăsescu, R., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03220.x · Cited by 528
Anti-NMDA receptor encephalitis in Japan
Iizuka, T., Sakai, F., Ide, T., Monzen, T., Yoshii, S., Iigaya, M., Suzuki, K., Lynch, D. R., Suzuki, N., Hata, T., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000278388.90370.c3 · Cited by 517
Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis
Malter, M. P., Helmstaedter, C., Urbach, H., Vincent, A. C., & Bien, C. G. (2009) · Annals of Neurology · doi:10.1002/ana.21917 · Cited by 510
Neuronal autoantigens—pathogenesis, associated disorders and antibody testing
Lancaster, E., & Dalmau, J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.99 · Cited by 512
Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice
Planagumà, J., Leypoldt, F., Mannara, F., Cuesta, J., Martín‐García, E., Aguilar, E., Titulaer, M. J., Petit‐Pedrol, M., Jain, A., Balice‐Gordon, R. J., et al. (2014) · Brain · doi:10.1093/brain/awu310 · Cited by 489
New-onset refractory status epilepticus
Gaspard, N., Foreman, B. P., Alvarez, V., Kang, C. M. C., Probasco, J. C., Jongeling, A. C., Meyers, E. E., Espinera, A. R., Haas, K. F., Schmitt, S. E., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001940 · Cited by 491
Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
Tüzün, E., & Dalmau, J. O. (2007) · The Neurologist · doi:10.1097/nrl.0b013e31813e34a5 · Cited by 477
Mechanisms of Autoantibody-Induced Pathology
Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00603 · Cited by 491
The Diagnosis and Treatment of Autoimmune Encephalitis
Lancaster, E. (2016) · Journal of Clinical Neurology · doi:10.3988/jcn.2016.12.1.1 · Cited by 456
Armangué, T., Titulaer, M. J., Málaga, I., Bataller, L., Gabilondo, I., Graus, F., & Dalmau, J. O. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.10.011 · Cited by 418
Leypoldt, F., Armangué, T., & Dalmau, J. O. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12553 · Cited by 424
Encephalitis and antibodies to synaptic and neuronal cell surface proteins
Lancaster, E., Martínez‐Hernández, E., & Dalmau, J. O. (2011) · Neurology · doi:10.1212/wnl.0b013e318224afde · Cited by 400
Antibodies and neuronal autoimmune disorders of the CNS
Graus, F., Saiz, A., & Dalmau, J. O. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5431-9 · Cited by 388
Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders
Dale, R. C., Merheb, V., Pillai, S. C., Wang, D., Cantrill, L. C., Murphy, T. K., Ben‐Pazi, H., Varadkar, S., Aumann, T. D., Horne, M. K., et al. (2012) · Brain · doi:10.1093/brain/aws256 · Cited by 392
Steiner, J. H., Walter, M., Glanz, W., Sarnyai, Z., Bernstein, H., Vielhaber, S., Kästner, A., Skalej, M., Jordan, W., Schiltz, K., et al. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.86 · Cited by 379
Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis
Martínez‐Hernández, E., Horvath, J. E., Shiloh‐Malawsky, Y., Sangha, N., Martinez‐Lage, M., & Dalmau, J. O. (2011) · Neurology · doi:10.1212/wnl.0b013e318228c136 · Cited by 372
Glutamate hypothesis in schizophrenia
Uno, Y., & Coyle, J. T. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12823 · Cited by 389
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg
Querol, L., Nogales‐Gadea, G., Rojas‐García, R., Díaz‐Manera, J., Pardo, J., Ortega-Moreno, A., Sedano, M. J., Gallardo, E., Berciano, J., Blesa, R., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000205 · Cited by 369
Acute mechanisms underlying antibody effects in anti–N‐methyl‐D‐aspartate receptor encephalitis
Moscato, E. H., Peng, X., Jain, A., Parsons, T. D., Dalmau, J. O., & Balice‐Gordon, R. J. (2014) · Annals of Neurology · doi:10.1002/ana.24195 · Cited by 371
Tüzün, E., Zhou, L., Baehring, J. M., Bannykh, S., Rosenfeld, M. R., & Dalmau, J. O. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0582-4 · Cited by 355
Sankowski, R., Mader, S., & Valdés-Ferrer, S. I. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00028 · Cited by 351
Seroprevalence of autoantibodies against brain antigens in health and disease
Dahm, L., Ott, C., Steiner, J. H., Stepniak, B., Teegen, B., Saschenbrecker, S., Hammer, C., Borowski, K., Begemann, M., Lemke, S., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24189 · Cited by 355
B cells in autoimmune and neurodegenerative central nervous system diseases
Sabatino, J. J., Pröbstel, A., & Zamvil, S. S. (2019) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0233-2 · Cited by 361
Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis
Mikasova, L., De Rossi, P., Bouchet, D., Georges, F., Rogemond, V., Didelot, A., Meissirel, C., Honnorat, J., & Groc, L. (2012) · Brain · doi:10.1093/brain/aws092 · Cited by 341
Geschwind, M. D., Shu, H., Haman, A., Sejvar, J. J., & Miller, B. L. (2008) · Annals of Neurology · doi:10.1002/ana.21430 · Cited by 322
Autoantibodies in neurological disease
Prüß, H. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00543-w · Cited by 335
Disease-relevant autoantibodies in first episode schizophrenia
Zandi, M. S., Irani, S. R., Lang, B., Waters, P. J., Jones, P. B., McKenna, P. J., Coles, A. J., Vincent, A. C., & Lennox, B. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5788-9 · Cited by 333
A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis
Balu, R., McCracken, L., Lancaster, E., Graus, F., Dalmau, J. O., & Titulaer, M. J. (2018) · Neurology · doi:10.1212/wnl.0000000000006783 · Cited by 312
Hammer, C., Stepniak, B., Schneider, A., Papiol, S., Tantra, M., Begemann, M., Sirén, A.-L., Pardo, L. A., Sperling, S., Mohd Jofrry, S., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.110 · Cited by 342
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Waters, P. J., Reindl, M., Saiz, A., Schanda, K., Tuller, F., Král, V., Nytrová, P., Sobek, O., Nielsen, H. H., Barington, T., et al. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312601 · Cited by 305
Zuliani, L., Graus, F., Giometto, B., Bien, C. G., & Vincent, A. C. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301237 · Cited by 292
Kreye, J., Wenke, N. K., Chayka, M., Leubner, J., Murugan, R., Maier, N., Jurek, B., Ly, L.-T., Brandl, D., Rost, B. R., et al. (2016) · Brain · doi:10.1093/brain/aww208 · Cited by 292
Gleichman, A. J., Spruce, L. A., Dalmau, J. O., Seeholzer, S. H., & Lynch, D. R. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0064-12.2012 · Cited by 292
A patient with encephalitis associated with NMDA receptor antibodies
Sansing, L. H., Tüzün, E., Ko, M. W., Baccon, J., Lynch, D. R., & Dalmau, J. O. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0493 · Cited by 290
Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis
Gable, M., Gavali, S. S., Radner, A. B., Tilley, D. H., Lee, B., Dyner, L., Collins, A. R., Dengel, A., Dalmau, J. O., & Glaser, C. A. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0799-0 · Cited by 289
The NMDA Receptor and Schizophrenia
Balu, D. T. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.01.006 · Cited by 303
The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis
van Sonderen, A., Petit‐Pedrol, M., Dalmau, J. O., & Titulaer, M. J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.43 · Cited by 274
Imaging of autoimmune encephalitis – Relevance for clinical practice and hippocampal function
Heine, J., Prüß, H., Bartsch, T., Ploner, C. J., Paul, F., & Finke, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.037 · Cited by 272
Burden of encephalitis-associated hospitalizations in the United States, 1998-2010
Vora, N. M., Holman, R. C., Mehal, J. M., Steiner, C. A., Blanton, J., & Sejvar, J. (2014) · Neurology · doi:10.1212/wnl.0000000000000086 · Cited by 264
Hacohen, Y., Wright, S. K., Waters, P. J., Agrawal, S., Carr, L., Cross, J. H., de Sousa, C., DeVile, C. J., Fallon, P., Gupta, R., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303807 · Cited by 268
Treatment strategies for autoimmune encephalitis
Shin, Y., Lee, S., Park, K., Jung, K., Jung, K., Lee, S. K., & Chu, K. (2017) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285617722347 · Cited by 272
Analysis of relapses in anti-NMDAR encephalitis
Gabilondo, I., Saiz, A., Galán, L., González, V., Jadraque, R., Sabater, L., Sans, A., Sempere, A., Vela, A., Villalobos, F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31822cfc6b · Cited by 264
Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA B R encephalitis
de Bruijn, M. A. A. M., van Sonderen, A., van Coevorden‐Hameete, M. H., Bastiaansen, A. E. M., Schreurs, M. W. J., Rouhl, R. P. W., van Donselaar, C. A., Majoie, M., Neuteboom, R. F., Smitt, P. A. E. S., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007475 · Cited by 266
Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric Patients
Herken, J., & Prüß, H. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00025 · Cited by 255
Paraneoplastic Anti–N-methyl-d-aspartate Receptor Encephalitis Associated with Ovarian Teratoma
Verma, A. (2008) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(08)79015-x · Cited by 252
in cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Kleiter, I., Ruprecht, K., Asgari, N., Pitarokoili, K., Borisow, N., Hümmert, M. W., Trebst, C., Pache, F. C., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0719-z · Cited by 257
Honorat, J. A., Komorowski, L., Josephs, K. A., Fechner, K., Louis, E. K. S., Hinson, S. R., Lederer, S., Kumar, N., Gadoth, A., Lennon, V. A., et al. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000385 · Cited by 255
Immunity and Inflammation in EpilepsyPreprint
Vezzani, A., Lang, B., & Aronica, E. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022699 · Cited by 254
Losing your nerves? Maybe it's the antibodies
Diamond, B., Huerta, P. T., Mina-Osorio, P., Kowal, C., & Volpe, B. T. (2009) · Nature Reviews Immunology · doi:10.1038/nri2529 · Cited by 247
Acute encephalitis – diagnosis and management
Ellul, M. A., & Solomon, T. (2018) · Clinical Medicine · doi:10.7861/clinmedicine.18-2-155 · Cited by 245
Anti-NMDA-receptor encephalitis: A severe, multistage, treatable disorder presenting with psychosis
Wandinger, K., Saschenbrecker, S., Stoecker, W., & Dalmau, J. O. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.09.012 · Cited by 243
Al‐Diwani, A., Handel, A. E., Townsend, L., Pollak, T. A., Leite, M. I., Harrison, P. J., Lennox, B., Okai, D., Manohar, S., & Irani, S. R. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30001-x · Cited by 249
Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis
Viaccoz, A., Desestret, V., Ducray, F., Picard, G., Cavillon, G., Rogemond, V., Antoine, J.-C. G., Delattre, J., & Honnorat, J. (2014) · Neurology · doi:10.1212/wnl.0000000000000126 · Cited by 235
Immune therapy in autoimmune encephalitis: a systematic review
Nosadini, M., Mohammad, S. S., Ramanathan, S., Brilot, F., & Dale, R. C. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1115720 · Cited by 241
Autoimmune seizures and epilepsy
Geis, C., Planagumà, J., Carreño, M., Graus, F., & Dalmau, J. O. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125178 · Cited by 241
Pillinger, T., D’Ambrosio, E., McCutcheon, R., & Howes, O. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0058-9 · Cited by 230
NMDA receptor encephalitis and other antibody-mediated disorders of the synapse
Dalmau, J. O. (2016) · Neurology · doi:10.1212/wnl.0000000000003414 · Cited by 229
VGKC-complex/LGI1-antibody encephalitis: Clinical manifestations and response to immunotherapy
Shin, Y., Lee, S., Shin, J.-W., Moon, J., Lim, J., Byun, J., Kim, T., Lee, K., Kim, Y.-S., Park, K., et al. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.10.005 · Cited by 227
Anti-NMDA receptor encephalitis, autoimmunity, and psychosis
Kayser, M. S., & Dalmau, J. O. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.007 · Cited by 224
N‐methyl‐ D ‐aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica
Dale, R. C., Irani, S. R., Brilot, F., Pillai, S. C., Webster, R., Gill, D. S., Lang, B., & Vincent, A. C. (2009) · Annals of Neurology · doi:10.1002/ana.21807 · Cited by 218
Blood Biomarkers of Ischemic Stroke
Jickling, G. C., & Sharp, F. R. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0050-4 · Cited by 219
Catatonia and the immune system: a review
Rogers, J. P., Pollak, T. A., Blackman, G., & David, A. S. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30190-7 · Cited by 221
Baumgärtner, A., Rauer, S., Mader, I., & Meyer, P. T. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7048-2 · Cited by 215
Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy
Lemke, J. R., Geider, K., Helbig, K. L., Heyne, H. O., Schütz, H., Hentschel, J., Courage, C., Depienne, C., Nava, C., Heron, D., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002740 · Cited by 200
Functional and structural brain changes in anti–N‐methyl‐D‐aspartate receptor encephalitis
Finke, C., Kopp, U. A., Scheel, M., Pech, L., Soemmer, C., Schlichting, J., Leypoldt, F., Brandt, A. U., Wuerfel, J. T., Probst, C., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23932 · Cited by 210
Glycine Receptor Autoimmune Spectrum With Stiff-Man Syndrome Phenotype
McKeon, A. B., Martínez‐Hernández, E., Lancaster, E., Matsumoto, J. Y., Harvey, R. J., McEvoy, K. M., Pittock, S. J., Lennon, V. A., & Dalmau, J. O. (2012) · JAMA Neurology · doi:10.1001/jamaneurol.2013.574 · Cited by 210
The NMDA receptor ‘glycine modulatory site’ in schizophrenia: d-serine, glycine, and beyond
Balu, D. T., & Coyle, J. T. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.004 · Cited by 208
Kępińska, A. P., Iyegbe, C. O., Vernon, A. C., Yolken, R., Murray, R. M., & Pollak, T. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00072 · Cited by 193
Paraneoplastic Syndromes Affecting the Nervous System
Khasraw, M., & Khakoo, Y. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00101-3 · Cited by 203
Neuronal surface antigen antibodies in limbic encephalitis
Graus, F., Saiz, A., Lai, M., Bruna, J., Lopez, F., Sabater, L., Blanco, Y., Rey, M. J., Ribalta, T., & Dalmau, J. O. (2008) · Neurology · doi:10.1212/01.wnl.0000325917.48466.55 · Cited by 203
Laurent, C., Capron, J., Quillerou, B., Thomas, G., Alamowitch, S., Fain, O., & MEKINIAN, A. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.008 · Cited by 199
Autoimmune encephalitis as differential diagnosis of infectious encephalitis
Armangué, T., Leypoldt, F., & Dalmau, J. O. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000087 · Cited by 199
Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort
Lee, W., Lee, S., Byun, J., Sunwoo, J., Kim, T., Lim, J., Moon, J., Lee, H. S., Shin, Y., Lee, K., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002635 · Cited by 197
Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology
Peery, H. E., Day, G. S., Dunn, S. E., Fritzler, M. J., Prüß, H., Souza, C. M. D., Doja, A., Mossman, K. L., Resch, L., Xia, C., et al. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.03.001 · Cited by 191
Secondary psychoses: an update
Keshavan, M. S., & Kaneko, Y. A. (2013) · World Psychiatry · doi:10.1002/wps.20001 · Cited by 191
Cell‐surface central nervous system autoantibodies: Clinical relevance and emerging paradigms
Irani, S. R., Gelfand, J. M., Al‐Diwani, A., & Vincent, A. C. (2014) · Annals of Neurology · doi:10.1002/ana.24200 · Cited by 185
Anti-NMDA Receptor Encephalitis in Psychiatry
Kayser, M. S., & Dalmau, J. O. (2011) · Current Psychiatry Reviews · doi:10.2174/157340011797183184 · Cited by 185
Antibodies to GABA A receptor α1 and γ2 subunits
Pettingill, P., Kramer, H., Coebergh, J. A., Pettingill, R., Maxwell, S., Nibber, A., Malaspina, A., Jacob, A., Irani, S. R., Buckley, C. J., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001326 · Cited by 183
Neuroleptic intolerance in patients with anti-NMDAR encephalitis
Lejuste, F., Thomas, L., Picard, G., Desestret, V., Ducray, F., Rogemond, V., Psimaras, D., Antoine, J.-C. G., Delattre, J., Groc, L., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000280 · Cited by 182
Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias
Mitoma, H., Adhikari, K., Aeschlimann, D. P., Chattopadhyay, P. P., Hadjivassiliou, M., Hampe, C. S., Honnorat, J., Joubert, B., Kakei, S., Lee, J., et al. (2015) · The Cerebellum · doi:10.1007/s12311-015-0664-x · Cited by 185
Diagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women With New-Onset Epilepsy
Niehusmann, P., Dalmau, J. O., Rudlowski, C., Vincent, A. C., Elger, C. E., Rossi, J., & Bien, C. G. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.5 · Cited by 176
Metadata
- Authors
- Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., Mason, W., Sansing, L. H., Dichter, M. A., Rosenfeld, M. R., & Lynch, D. R.
- Affiliations
- University of Pennsylvania (US)
- Augusta University (US)
- Yale University (US)
- Jichi Medical University (JP)
- Tokyo Metropolitan Neurological Hospital (JP)
- Children's Hospital of Pittsburgh (US)
- Princess Margaret Cancer Centre (CA)
- Corresponding author
- Dalmau, Josep
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 61
- Issue
- 1
- Pages
- 25-36
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC2430743
- OpenAlex
- W2114398221
- Cited by
- 2,492
- References
- 37
- Citations by year
- 2026: 105 · 2025: 122 · 2024: 142 · 2023: 135 · 2022: 168 · 2021: 190 · 2020: 158 · 2019: 179 · 2018: 128 · 2017: 152 · 2016: 158 · 2015: 145 · 2014: 129 · 2013: 143 · 2012: 113
- FWCI
- 47.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA089054, R01CA107192)
- National Institute of Neurological Disorders and Stroke (R01NS045986)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Clinical Neurology › Myasthenia Gravis and Thymoma
- Keywords
- paraneoplastic encephalitis, anti-NMDA receptor encephalitis, ovarian teratoma, NMDA receptor subunits, NR2B, NR2A, autoantibodies, hippocampal neurons, autoimmune encephalitis, tumor resection, immunotherapy, microglial activation, neurodegeneration, psychiatric symptoms, amnesia, seizures
- MeSH terms
- Adolescent, Adult, Animals, Antibodies, Dissection, Encephalitis, Female, Humans, Immunohistochemistry, Immunosuppressive Agents, Magnetic Resonance Imaging, Male, Neurons, Ovarian Neoplasms, Teratoma, Transfection, Gene Expression Regulation, Neoplastic, Receptors, N-Methyl-D-Aspartate, Treatment Outcome, Rats, Wistar, Protein Subunits, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
